AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $326,000 | -63.5% | 9,021 | -37.9% | 0.44% | -47.3% |
| Q3 2018 | $894,000 | -25.0% | 14,517 | -17.8% | 0.84% | -23.4% |
| Q2 2018 | $1,192,000 | +19.9% | 17,650 | -3.7% | 1.09% | +4.9% |
| Q1 2018 | $994,000 | +33.4% | 18,321 | +47.0% | 1.04% | +36.9% |
| Q4 2017 | $745,000 | +5.2% | 12,466 | -14.5% | 0.76% | -12.2% |
| Q3 2017 | $708,000 | +57.3% | 14,577 | +70.3% | 0.87% | +27.3% |
| Q2 2017 | $450,000 | – | 8,558 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |